期刊文献+

促红细胞生成素治疗肾性贫血研究进展 被引量:6

Progress of erythropoietin for patients with renal anemia
下载PDF
导出
摘要 促红细胞生成素(EPO)主要由肾脏产生,其作用为调节红细胞生成。EPO缺乏可致贫血,重组促红细胞生成素(rHuEPO)治疗慢性肾衰引起的贫血疗效确切且不良反应小。本文综述EPO的生理功能、临床应用及新品种开发。 Erythropoietin (EPO) produced by the kidney in adults is a kind of glycoprotein hormone, which regulates red cell production. Lacking of EPO anemia. Treatment with recombinant human EPO (rHuEPO) is an effective and safe approach to improve anemia associated with chronic renal failure (CRF). This review summarizes the physiological function, clinical application and development of EPO.
作者 俞岗 汪年松
出处 《世界临床药物》 CAS 2011年第2期88-92,共5页 World Clinical Drug
关键词 促红细胞生成素 贫血 慢性肾衰 erythropoietin anemia chronic renal failure
  • 相关文献

参考文献33

  • 1Fisher JW, Koury S, Ducey T, et al. Erythropoietin production by interstitial cells of hypoxic monkeys kidneys [J]. Br J Haematol, 1996, 95 (1): 27-32. 被引量:1
  • 2Bernaudin M, BellailA, Marti HH, et al. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain [J]. Glia, 2000, 30 (3) : 271-278. 被引量:1
  • 3邹和群.慢性肾脏病患者脑血管病的预防[J].中华肾脏病杂志,2005,21(3):169-171. 被引量:12
  • 4Sasaki R, Masuda S, Nagao M. Pleiotropic functions and tissue-specific expression of erythropoietin [J]. News Physiol Sci, 2001, 16: 110-113. 被引量:1
  • 5Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis [J]. J Exp Med, 2003, 198 (6) : 971-975. 被引量:1
  • 6Becerra SP, Amaral J. Erythropoietin-an endogenous retinal survival factor[J]. N Engl J Med, 2002, 347 (24) : 1968-1970. 被引量:1
  • 7Bagnis C, Beaufils H, Jacquiaud C, et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat [J]. Nephrol Dial Trans, 2001, 16 (5) : 932-938. 被引量:1
  • 8Besarab A, BoltonWK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin[J]. N Engl J Med, 1998, 339 (9) : 584-590. 被引量:1
  • 9Singh AK, Szczech L, Tang KL, et al. CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease [J]. New Engl J Med, 2006, 355 (20): 2085-2098. 被引量:1
  • 10Drueke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patientswith chronic kidney disease and anemia[J]. New Engl J Med, 2006, 355 (20) : 2071-2084. 被引量:1

二级参考文献40

  • 1郭峰 虞紫茜.红细胞免疫功能的初步研究[J].中华医学杂志,1982,62:715-717. 被引量:264
  • 2郭峰 张延东.血清对红细胞免疫粘附抑制作用的测定[J].上海免疫学杂志,1987,7(3):133-133. 被引量:27
  • 3郭峰 姚个金 等.血清中红细胞免疫粘附促进因子的测定[J].上海免疫学杂志,1988,8(6):440-440. 被引量:32
  • 4Rossert J, Casadevall N, Eckardt KU. Anti-erythropoietin antibodies and pure red cell aplasia. J Am Soc Nephrol,2004,15:398-406.?A?A?A 被引量:1
  • 5Bergrem H, Danielson BG, Eckardt KU,et al. A case of anti-erythropoietin antibodies following recombinant human erythropoietin treatment. In: Bauer C, Koch KM, Scigalla P.eds.Erythropoietin: molecular physiology and clinical application.New York: Marcel Dekker, 1993.266-275. 被引量:1
  • 6Voulgari PV, Chaidos A, Tzouvara E, et al. Antierythropoietin antibodies in thalassemia patients. Ann Hematol, 2004, 83:22-27. 被引量:1
  • 7Tzioufas A, Kokori S, Petrovas C, et al. Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus. Arthritis Rheum, 1997,40:2212-2216. 被引量:1
  • 8Castelli G, Famularo A, Semino C, et al. Detection of antierythropoietin antibodies in haemodialysis patients treated with recombinant human - erythropoietin. Pharmacol Res, 2000,41:313-318. 被引量:1
  • 9Wu G, Nathoo B, Mendelssohn D, et al. Antibody to erythropoietin in surveillance study in 5 Ontario renal centers.Nephrol Dial Transplant, 2003,18 Suppl 4:162. 被引量:1
  • 10Eckardt KU, Casadevall N. Pure red-cell aplasia due to antierythropoietin antibodies, Nephrol Dial Transplant,2003,18:865-869. 被引量:1

共引文献99

同被引文献52

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部